Anthera Pharmaceuticals, Inc. (ANTH) At $1.56 Forms Bottom; LINDT & SPRUNGLI AG (LDSVF) Shorts Decreased By 14%

February 10, 2018 - By John Hoffman

LINDT & SPRUNGLI AG (OTCMKTS:LDSVF) had a decrease of 14% in short interest. LDSVF’s SI was 4,300 shares in February as released by FINRA. Its down 14% from 5,000 shares previously. With 100 avg volume, 43 days are for LINDT & SPRUNGLI AG (OTCMKTS:LDSVF)’s short sellers to cover LDSVF’s short positions. It closed at $5800 lastly. It is down 0.00% since February 10, 2017 and is . It has underperformed by 16.70% the S&P500.

Anthera Pharmaceuticals, Inc. (ANTH) formed multiple bottom with $1.51 target or 3.00% below today’s $1.56 share price. Anthera Pharmaceuticals, Inc. (ANTH) has $21.61M valuation. It closed at $1.56 lastly. It is down 93.94% since February 10, 2017 and is downtrending. It has underperformed by 110.64% the S&P500.

Among 6 analysts covering Anthera Pharmaceuticals (NASDAQ:ANTH), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Anthera Pharmaceuticals has $15 highest and $1.35 lowest target. $6.20’s average target is 297.44% above currents $1.56 stock price. Anthera Pharmaceuticals had 17 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was initiated by Suntrust Robinson on Wednesday, September 9 with “Buy”. Piper Jaffray maintained the stock with “Overweight” rating in Thursday, December 29 report. The firm has “Buy” rating given on Thursday, September 17 by Citigroup. The stock of Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) has “Hold” rating given on Thursday, August 13 by Zacks. H.C. Wainwright maintained the stock with “Buy” rating in Thursday, December 29 report. SunTrust initiated the stock with “Buy” rating in Wednesday, September 9 report. Citigroup downgraded the shares of ANTH in report on Thursday, December 29 to “Neutral” rating. Jefferies downgraded Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) on Thursday, December 29 to “Hold” rating. The rating was maintained by Jefferies with “Hold” on Tuesday, September 12. As per Friday, July 8, the company rating was initiated by H.C. Wainwright.

Analysts await Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) to report earnings on February, 26. They expect $-0.82 EPS, up 71.53% or $2.06 from last year’s $-2.88 per share. After $-0.58 actual EPS reported by Anthera Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 41.38% negative EPS growth.

Chocoladefabriken Lindt & Sprüngli AG, together with its subsidiaries, develops, produces, and sells chocolate products worldwide. The company has market cap of $14.84 billion. The firm sells its products under the Lindt, Ghirardelli, Russell Stover, Whitman’s, Caffarel, Hofbauer, Küfferle, and Pangburn’s brand names. It has a 3.08 P/E ratio.